Axcynsis Therapeutics
Singapore
About Axcynsis Therapeutics
Tetris Therapeutics is a platform-based biotechnology company focusing on the development of antibody drug conjugate (ADC) therapies to revolutionise cancer treatments. Leveraging on proprietary technologies, we are developing a robust pipeline of ADC candidates with the potential to address unmet medical needs for new treatment options.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Seed
- Last round: Seed (May 2022)
- Website: tetris.com.sg
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/axcynsis-therapeutics-84206 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.